Burlington, Massachusetts, November 19, 2018 — MilliporeSigma recognized three graduate students who have demonstrated innovation in life science at an awards ceremony at the company’s global headquarters in Darmstadt, Germany recently.
Twelve finalists from across the globe (four in each of three awards categories: bioseparations, food & beverage safety, and tumor biology) presented their research to an audience of MilliporeSigma scientists, and guests as part of the 2018 Life Science Awards. Yu Cai, Yanqi Qu and Jun Ho Lee were each named winners of the $10,000 grand prize in their respective categories.
“This year’s Life Science Award winners generated new insights into areas of deep interest to the applied sciences,” said Udit Batra, CEO, MilliporeSigma. “Each winner is not only a good scientist, they are curiously solving the toughest problems in life science,” he added.
Following is a list of the grand prize winners and their research topics:
Food & Beverage Safety
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has some 22,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck KGaA, Darmstadt, Germany generated sales of €16.2 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.